Cargando…

Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines

PURPOSE: Brachytherapy (BT) forms major treatment modality in squamous cell carcinoma of head and neck cancers (HNC). However, there is a dearth of literature and guidelines for the use in various indications. High-dose-rate brachytherapy (HDR-BT) in Indian scenario is an important treatment modalit...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhalavat, Rajendra, Budrukkar, Ashwini, Laskar, Sarbani Ghosh, Sharma, Dayanand, Mukherji, Ashutosh, Chandra, Manish, Mahantshetty, Umesh, Pareek, Vibhay, Bauskar, Pratibha, Saraf, Sonali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701929/
https://www.ncbi.nlm.nih.gov/pubmed/33299441
http://dx.doi.org/10.5114/jcb.2020.100385
_version_ 1783616512150470656
author Bhalavat, Rajendra
Budrukkar, Ashwini
Laskar, Sarbani Ghosh
Sharma, Dayanand
Mukherji, Ashutosh
Chandra, Manish
Mahantshetty, Umesh
Pareek, Vibhay
Bauskar, Pratibha
Saraf, Sonali
author_facet Bhalavat, Rajendra
Budrukkar, Ashwini
Laskar, Sarbani Ghosh
Sharma, Dayanand
Mukherji, Ashutosh
Chandra, Manish
Mahantshetty, Umesh
Pareek, Vibhay
Bauskar, Pratibha
Saraf, Sonali
author_sort Bhalavat, Rajendra
collection PubMed
description PURPOSE: Brachytherapy (BT) forms major treatment modality in squamous cell carcinoma of head and neck cancers (HNC). However, there is a dearth of literature and guidelines for the use in various indications. High-dose-rate brachytherapy (HDR-BT) in Indian scenario is an important treatment modality, and the recommendations in this guidelines aim to provide the necessary recommendations for the use of HDR-BT for uniform application across the country in patients with HNC. MATERIAL AND METHODS: A panel consisting of members of the Indian Brachytherapy Society (IBS), based on their clinical experience was invited. The process involved defining important steps, precautions, target volumes and indications, thorough literature review, and discussion with fellow members. The guidelines were established and formulated the recommendations for HDR-BT based on available evidences and individual experience for sites, relevant to Indian settings. RESULTS: The IBS recommends the use of HDR brachytherapy as a part of treatment of head and neck tumors. The scope of these guidelines and recommendations included practical suggestions, ensuring efficient use of brachytherapy treatment as radical with external beam radiotherapy (EBRT) boost, palliative and adjuvant as definitive, or re-radiation as salvage for HNC in India. The IBS has made specific site-wise recommendations for previously untreated and recurrent HNC patients on their selection criteria, implant techniques, target volume definition, and HDR treatment parameters, such as time, dose rate, total dose, and fractionation schedules. Limited experience exists with HDR-BT in patients with head and neck cancers in India and across the globe. CONCLUSIONS: IBS provided a consensus statement and guidelines for the head and neck brachytherapy and believed that these recommendations will overcome the fear of practicing radiation oncologists. This should generate interest amongst students and will help radiation oncologists all across the country to use the art of brachytherapy carefully in HNC patients, with better curative and salvage options.
format Online
Article
Text
id pubmed-7701929
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-77019292020-12-08 Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines Bhalavat, Rajendra Budrukkar, Ashwini Laskar, Sarbani Ghosh Sharma, Dayanand Mukherji, Ashutosh Chandra, Manish Mahantshetty, Umesh Pareek, Vibhay Bauskar, Pratibha Saraf, Sonali J Contemp Brachytherapy Original Paper PURPOSE: Brachytherapy (BT) forms major treatment modality in squamous cell carcinoma of head and neck cancers (HNC). However, there is a dearth of literature and guidelines for the use in various indications. High-dose-rate brachytherapy (HDR-BT) in Indian scenario is an important treatment modality, and the recommendations in this guidelines aim to provide the necessary recommendations for the use of HDR-BT for uniform application across the country in patients with HNC. MATERIAL AND METHODS: A panel consisting of members of the Indian Brachytherapy Society (IBS), based on their clinical experience was invited. The process involved defining important steps, precautions, target volumes and indications, thorough literature review, and discussion with fellow members. The guidelines were established and formulated the recommendations for HDR-BT based on available evidences and individual experience for sites, relevant to Indian settings. RESULTS: The IBS recommends the use of HDR brachytherapy as a part of treatment of head and neck tumors. The scope of these guidelines and recommendations included practical suggestions, ensuring efficient use of brachytherapy treatment as radical with external beam radiotherapy (EBRT) boost, palliative and adjuvant as definitive, or re-radiation as salvage for HNC in India. The IBS has made specific site-wise recommendations for previously untreated and recurrent HNC patients on their selection criteria, implant techniques, target volume definition, and HDR treatment parameters, such as time, dose rate, total dose, and fractionation schedules. Limited experience exists with HDR-BT in patients with head and neck cancers in India and across the globe. CONCLUSIONS: IBS provided a consensus statement and guidelines for the head and neck brachytherapy and believed that these recommendations will overcome the fear of practicing radiation oncologists. This should generate interest amongst students and will help radiation oncologists all across the country to use the art of brachytherapy carefully in HNC patients, with better curative and salvage options. Termedia Publishing House 2020-10-30 2020-10 /pmc/articles/PMC7701929/ /pubmed/33299441 http://dx.doi.org/10.5114/jcb.2020.100385 Text en Copyright © 2020 Termedia http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY -NC -SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Original Paper
Bhalavat, Rajendra
Budrukkar, Ashwini
Laskar, Sarbani Ghosh
Sharma, Dayanand
Mukherji, Ashutosh
Chandra, Manish
Mahantshetty, Umesh
Pareek, Vibhay
Bauskar, Pratibha
Saraf, Sonali
Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines
title Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines
title_full Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines
title_fullStr Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines
title_full_unstemmed Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines
title_short Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines
title_sort brachytherapy in head and neck malignancies: indian brachytherapy society (ibs) recommendations and guidelines
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701929/
https://www.ncbi.nlm.nih.gov/pubmed/33299441
http://dx.doi.org/10.5114/jcb.2020.100385
work_keys_str_mv AT bhalavatrajendra brachytherapyinheadandneckmalignanciesindianbrachytherapysocietyibsrecommendationsandguidelines
AT budrukkarashwini brachytherapyinheadandneckmalignanciesindianbrachytherapysocietyibsrecommendationsandguidelines
AT laskarsarbanighosh brachytherapyinheadandneckmalignanciesindianbrachytherapysocietyibsrecommendationsandguidelines
AT sharmadayanand brachytherapyinheadandneckmalignanciesindianbrachytherapysocietyibsrecommendationsandguidelines
AT mukherjiashutosh brachytherapyinheadandneckmalignanciesindianbrachytherapysocietyibsrecommendationsandguidelines
AT chandramanish brachytherapyinheadandneckmalignanciesindianbrachytherapysocietyibsrecommendationsandguidelines
AT mahantshettyumesh brachytherapyinheadandneckmalignanciesindianbrachytherapysocietyibsrecommendationsandguidelines
AT pareekvibhay brachytherapyinheadandneckmalignanciesindianbrachytherapysocietyibsrecommendationsandguidelines
AT bauskarpratibha brachytherapyinheadandneckmalignanciesindianbrachytherapysocietyibsrecommendationsandguidelines
AT sarafsonali brachytherapyinheadandneckmalignanciesindianbrachytherapysocietyibsrecommendationsandguidelines